Diabetes and heart failure: epidemiology, pathophysiology and management.
Desai
Akshay S
AS
Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, USA. adesai@partners.org
O'Gara
Patrick T
PT
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002227:Carbazoles / Q000627:therapeutic use; D000077261:Carvedilol; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000503:physiopathology* / Q000517:prevention & control; D003925:Diabetic Angiopathies / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology* / Q000517:prevention & control; D003928:Diabetic Nephropathies / Q000517:prevention & control; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D011412:Propanolamines / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002227:Carbazoles; D000451:Mineralocorticoid Receptor Antagonists; D011412:Propanolamines; D000077261:Carvedilol; D013148:Spironolactone